Publications

Steve Finkbeiner, MD, PhDBarmada S, Finkbeiner S. Bringing SOD1 into the fold. Nat Neurosci. 2010 Nov; 13(11):1303-4. View in: PubMed
Steve Finkbeiner, MD, PhDHuntington's Disease. View in: PubMed
Steve Finkbeiner, MD, PhDPeebles CL, Yoo J, Thwin MT, Palop JJ, Noebels JL, Finkbeiner S. Arc regulates spine morphology and maintains network stability in vivo. Proc Natl Acad Sci U S A. 2010 Oct 19; 107(42):18173-8. View in: PubMed
Steve Finkbeiner, MD, PhDDirect membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. View in: PubMed
Steve Finkbeiner, MD, PhDKratter IH, Finkbeiner S. PolyQ disease: too many Qs, too much function? Neuron. 2010 Sep 23; 67(6):897-9. View in: PubMed
Steve Finkbeiner, MD, PhDA compact beta model of huntingtin toxicity. View in: PubMed
Steve Finkbeiner, MD, PhDFinkbeiner S. Bridging the Valley of Death of therapeutics for neurodegeneration. Nat Med. 2010 Nov; 16(11):1227-32. View in: PubMed
Steve Finkbeiner, MD, PhDTsvetkov AS, Miller J, Arrasate M, Wong JS, Pleiss MA, Finkbeiner S. A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc Natl Acad Sci U S A. 2010 Sep 28; 107(39):16982-7. View in: PubMed
Steve Finkbeiner, MD, PhDBringing SOD1 into the fold. View in: PubMed
Steve Finkbeiner, MD, PhDVossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, Cui B, Mucke L. Tau reduction prevents Abeta-induced defects in axonal transport. Science. 2010 Oct 8; 330(6001):198. View in: PubMed